Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury (Retraction of vol 21, pg 164, 2007)

Hagiwara Satoshi; Iwasaka Hideo; Noguchi Takayuki

首页> 外文期刊>Journal of anesthesia >Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury (Retraction of vol 21, pg 164, 2007)

【24h】

Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury (Retraction of vol 21, pg 164, 2007)

机译：甲磺酸萘法莫他抑制脂多糖诱导的急性肺损伤中HMGB1的表达（第21卷撤消，第164页，2007年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of anesthesia》 |2015年第3期|共1页
作者
Hagiwara Satoshi; Iwasaka Hideo; Noguchi Takayuki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury (Retraction of vol 21, pg 164, 2007) [J] . Hagiwara Satoshi, Iwasaka Hideo, Noguchi Takayuki Journal of anesthesia . 2015,第3期

机译：甲磺酸萘法莫他抑制脂多糖诱导的急性肺损伤中HMGB1的表达（第21卷撤消，第164页，2007年）
2. Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury [J] . Satoshi Hagiwara, Hideo Iwasaka, Takayuki Noguchi Journal of Anesthesia . 2007,第2期

机译：甲磺酸萘法莫他抑制脂多糖诱导的急性肺损伤中HMGB1的表达
3. Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. [J] . Hidaka S, Iwasaka H, Hagiwara S, Journal of Surgical Research: Clinical and Laboratory Investigation . 2011,第1期

机译：甲磺酸加倍酯抑制脂多糖诱导的急性肺损伤中HMGB1的表达。
4. The a7nAChR agonist GTS-21 significantly attenuates hyperoxic acute lung injury and increases bacterial clearance. [D] . Sitapara, Ravikumar. 2016

机译：a7nAChR激动剂GTS-21可显着减轻高氧急性肺损伤并增加细菌清除率。
5. MicroRNA-21 inhibits lipopolysaccharide-induced acute lung injury by targeting nuclear factor-κB [O] . Wei-Dong Zhu, Jia Xu, Mao Zhang, -1

机译：MicroRNA-21通过靶向核因子-κB抑制脂多糖诱导的急性肺损伤
6. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial [O] . Morihisa Hirota, Tooru Shimosegawa, Katsuya Kitamura, 2019

机译：连续的区域动脉输注与静脉施用蛋白酶抑制剂Nafamostat介于预测严重急性胰腺炎的介质：多中心，随机，开放标签，第2期试验

Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury (Retraction of vol 21, pg 164, 2007)

著录项

相似文献

相关主题

期刊订阅